![Arvin Yang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Arvin Yang worked as the Chief Medical Officer & Senior Vice President at Mersana Therapeutics, Inc. from 2020 to 2023.
Prior to that, he worked as the Vice President at Melanoma Diagnostics, Inc. Dr. Yang holds a doctorate degree from Robert Wood Johnson Medical School.
Anciens postes connus de Arvin Yang
| Sociétés | Poste | Fin |
|---|---|---|
| MERSANA THERAPEUTICS | Directeur Technique/Scientifique/R&D | 29/09/2023 |
Melanoma Diagnostics, Inc. | Corporate Officer/Principal | - |
Formation de Arvin Yang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Robert Wood Johnson Medical School
 Robert Wood Johnson Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melanoma Diagnostics, Inc. |
